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Background: Both physical activity and inflammation are important in the pathophysiology of metabolic syndrome
(MetS). Our study aim is to explore their associations in an elderly male (≥ 65 years old) cohort.
Methods: We enrolled 309 elderly male residents (mean age: 74.4 ± 6.0 years) in a remote southern Taiwan
community. The physical activity was recorded by a standard questionnaire. A high-sensitivity C-reactive protein
(hsCRP) level > 3.0 mg/L indicated a high inflammatory status.
Results: The total prevalence rate of MetS was 27.8% in this male geriatric cohort. Median hsCRP levels were
significantly higher in the MetS group (1.60 ± 0.7 vs. 1.0 ± 0.3 mg/L, p < 0.01), and the risk of elevated hsCRP increased
with escalating MetS components (p for trend < 0.001). The non-MetS group had higher amount of median weekly
physical activity (183.1 ± 19.0 vs. 173.5 ± 10.6 MET-hr/week, p = 0.029), which was also higher among those with lower
hsCRP levels (186.1 ± 14.1 vs. 167.8 ± 38.5 MET-hr/week, p = 0.013). Multivariate analysis showed that higher body mass
index (ORs: 1.527, 95% CI: 1.319-1.768, p < 0.01) insulin (OR: 1.128, 95% CI: 1.045-1.218, p < 0.01) and physical activity
(ORs: 0.997, 95% IC: 0.994-0.999, p < 0.05) were independent predictors of MetS, but not hsCRP level (p > 0.05).
Conclusions: Reduced physical activity was one major pathophysiological MetS factor in our Asian geriatric
participants.
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In 1988, the concept of metabolic syndrome (MetS), a
cluster of metabolic factors, was proposed [1]. MetS is not
a single disease, but a syndrome that causes physiological
abnormalities such as abnormal vascular function, impaired
glucose tolerance, and abnormal coagulation factors, all of
which increase the risk of poor outcomes for diabetes
mellitus (DM) and cardiovascular disorders [2,3]. Obesity
[4,5], physical activity [6-8], and inflammation [9,10]
may be the major pathophysiological factors of MetS.* Correspondence: larry@mail.ncku.edu.tw
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reproduction in any medium, provided the orIt is still unclear that the association is true in the elderly
(≥ 65 years old). We thus explored the association be-
tween MetS, physical activity, and low-grade inflammation
markers, presented by high-sensitivity C-reactive protein
(hsCRP) concentrations in elderly men in a remote area of
southern Taiwan.
hsCRP is one indicator of inflammation. When develop-
ing inflammation, plasma hsCRP level elevates abruptly;
therefore, it is referred to as a biomarker of low-grade
inflammation. In addition, adipose tissue releases many
inflammatory cytokines, such as interleukin-6 and tumor
necrosis factor-α, which elevate plasma hsCRP levels [9].
Aging process also elevates plasma hsCRP levels [9,11].
Higher plasma hsCRP levels are associated with an in-
creased the risk of DM [10,12-15] and cardiovascularLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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related to MetS [9,10,13,15,19,20] and the components
of MetS [19].
Lower physical activity in healthy young adults is associ-
ated with abnormal metabolic consequences such as de-
creased insulin sensitivity and increased abdominal fat [21],
which links many components of MetS. Inflammation also
induces insulin resistance [21]. A higher-level physical ac-
tivity was reported to be associated with decrease plasma
hsCRP level [22], which is an indicator of lower inflamma-
tory status. To our best knowledge, it remained unclear
whether the association between hsCRP and the strength of
daily physical activity regarding MetS is true in the elderly
population. We thus hypothesized that though the elderly
population might have average higher levels of lower-grade
inflammation status indicated by hsCRP levels, higher
physical activity could be related to less abnormal metabolic
profiles in an aging community survey.
Methods
Study population and data collection
According to the public health database in 2010 from the
National Health Research Institute in Taiwan, Tianliao was
the third-fastest aging village in Taiwan and the highest per-
centage of elderly residents in southern Taiwan. In addition,
the village had only limited medical resources. According to
the August 2010 census [23], there were 8,421 people (4,583
men; 3,658 women) in the village and the rate of people
older than 65 years of age was 10.5% in Taiwan, but 24.1%
in Tianliao. In addition, based on the aging index, defined
by equation as the ratio of ([(population ≥ 65 years old)/
(population ≤ 14 years old)] × 100), was as high as 299%,
Tianliao could be classified as a “severely aging village”.
The study surveyed voluntary men residents over ≥
65 years old in this remote aging community in July and
August 2010. According to the census, there were 1,012
men ≥ 65 years old in Tianliao. Those who wished to par-
ticipate in the study were called to the nearest public health
examination station via the public address broadcasting sys-
tem or door-to-door invitation. Except for 62 men who
were disabled and 269 men who did not live there, only 681
of those recruited were eligible, 414 men agreed to partici-
pate in our study. The response rate was 60.8% and the stat-
istical power was 0.80. There were no significant differences
in background or age distribution between participants and
non-participants. Each participant underwent a structured
questionnaire interview and a blood test. The study proto-
col was approved by the National Cheng Kung University
ethics committee (IRB no: ER-99-111), and all participants
signed an informed consent form before the study began.
Questionnaire design
A standardized face-to-face interview based on structured
questionnaires was conducted by well-trained interviewers.The questionnaire asked about participant’s medical history,
as well as physical activity.
Physical activity
Self-reported physical activity in usual seven days was
calculated through the Taiwanese version of short form of
international physical activity questionnaire (IPAQ). The
total hours over the last seven days spent on vigorous and
moderate-intensity physical activity, walking and sitting was
obtained through IPAQ. The amount of physical activity
was converted to metabolic equivalent task hours per week
(MET-hr/week) according to the IPQA scoring protocol
[24]. The formula we applied for the average MET score
were calculated from each type of physical activity:
vigorous physical activity = 8.0 METs, moderate physical
activity = 4.0 METs, walking = 3.3 METs, sitting = 1 MET,
and total physical activity = sum of vigorous +moderate +
walking + sitting MET-hr/week scores.
Definition of MetS and DM
MetS was defined, based upon the National Cholesterol
Education Program Adult Treatment Panel III (NCEP-
ATPIII) with criteria modified in 2005 for Asian Americans
[25], as presenting 3 or more of the following components:
(1) waist circumference ≥ 90 cm for men; (2) triglycerides ≥
150 mg/dL; (3) HDL-C < 40 mg/dL for men; (4) blood
pressure ≥ 130/85 mmHg or current use of antihyper-
tensive medication; (5) fasting glucose ≥ 100 mg/dL.
DM was defined according to the American Diabetes
Association 2010 diagnostic criteria [26] and the medical
history reported by each participant.
Laboratory methods
After the participants had fasted for at least 8 hours,
peripheral blood samples were collected from them and
centrifuged at 3,000 rpm for 15 min at 4°C. The samples
were frozen and then sent to a central laboratory for ana-
lysis. Measurement of insulin, fasting glucose, hemoglobin
A1c (HbA1C), total cholesterol, high-density lipoprotein
(HDL-C), low-density lipoprotein (LDL-C), and triglyceride
levels were described by previous study [8]. Level of hsCRP
was measured using a particle-enhanced turbidimetric
assay. In this study, we used the cut-off value of hsCRP to
predict high level of inflammation by the criteria set by the
American Heart Association [27], which defines a plasma
hsCRP level > 3.0 mg/L to be as a high hsCRP level.
Statistical analysis
Data management and statistical analyses were performed
with SPSS 12.0. Continuous variables with a normal distri-
bution (fasting glucose, total cholesterol, HDL-C, LDL-C,
waist circumference, height, weight, body fat, and body
mass index (BMI)) were expressed as means ± standard
deviation (SD). Continuous variables with a non-normal
Table 1 Clinical characteristics: comparison between
non-MetS and MetS groups
Variation Non-MetS (n = 223) MetS (n = 86)
Age (years)* 74 ± 0.4 74 ± 0.6
hsCRP (mg/L)* 1.0 ± 0.3 1.6 ± 0.7**
ATP III MetS criteria (%)
Hypertension 71.7 89.5**
Increased waist 18.8 74.4***
Low HDL-C 9.9 70.9***
Hyperglycemia 21.5 59.3***
High triglyceride 3.6 51.2***
Fasting glucose (mg/dL) 93.7 ± 7.7 101.5 ± 10.6***
Insulin (uIU/mL)* 4.8 ± 0.3 9.4 ± 1.4***
Cholesterol (mg/dL) 194.5 ± 36.2 194.1 ± 33.7
Triglycerides (mg/dL)* 84.0 ± 2.1 151 ± 9.0***
LDL-C (mg/dL) 124.8 ± 31.0 123.0 ± 31.7
HDL-C (mg/dL) 51.4 ± 11.1 38.5 ± 6.7***
Waist (cm) 82.2 ± 10.3 94.2 ± 7.6***
Height (cm) 160.9 ± 5.9 161.8 ± 5.4
Weight (kg) 59.5 ± 8.2 69.4 ± 8.3***
BMI (kg/m2) 23.0 ± 2.7 26.5 ± 2.8***
Body fat* 18.8 ± 6.2 23.3 ± 0.6***
Physical activity(MET-hr/week) 183.1 ± 19.0 173.5 ± 10.6*
MetSC* 1 ± 0.05 3 ± 0.07***
Smoke, current 17 17.4
Liver disease (%) 3.6 4.7
Stroke (%) 3.1 10.5*
Heart disease (%) 13.0 18.6
Arrhythmia (%) 2.2 3.5
Cardiac catheterization (%) 4.0 4.7
1. Continuous variables with normal distribution are mean ± standard deviation
(SD) and with non-normal distribution (variation*) are median ± standard error
(SE). Categorical variables are reported as numbers and percentages, as indicated.
2. Continuous variables with normal distribution were tested using Student’s
t test; otherwise, Mann–Whitney U test was used. Comparisons between
categorical variables were made using a χ2 test. *p <0.05; **p <0.01; ***p <0.001.
Abbreviations: ATP III = Adult Treatment Panel III; BMI = body mass index;
HDL-C = high-density lipoprotein; hsCRP = high-sensitivity C-reactive protein;
LDL-C = low-density lipoprotein; MetS =metabolic syndrome.
Chang et al. Diabetology & Metabolic Syndrome 2013, 5:60 Page 3 of 8
http://www.dmsjournal.com/content/5/1/60distribution (age, hsCRP level, insulin, triglycerides,
components of MetS, physical activity, and quantity of
alcohol consumed) were expressed as means ± standard
error (SE). Categorical variables were reported as num-
bers and percentages. Normality was tested using the
Kolmogorov-Smirnov test. Continuous variables were
compared using a Student’s t test for normally distributed
values; otherwise, a non-parametric Mann–Whitney U test
was used. Comparisons between categorical variables
were made using a χ2 test. Spearman partial correlation
coefficients of hsCRP and components of MetS were
calculated. Odds ratios (ORs) and 95% confidence intervals
(CI) were assessed using logistic regression. Statistical tests
were 2-sided; significance was set at p < 0.05.
Results
We enrolled 309 participants (all gentlemen; mean age:
74.4 ± 6.0 years; range: 65–98 years) for analysis. Excluded
were 9 with various treatment strategies and 96 with a
history of DM. The prevalence of high blood pressure was
76.7%; the mean waist circumference was 85.6 ± 11.0 cm,
HDL-C was 47.8 ± 11.6 mg/dL, and fasting glucose was
95.9 ± 9.3 mg/dL; and the median hsCRP was 1.3 ± 0.3 mg/L,
weekly physical activity was 179.53 ± 14.14 MET-hr/week
and triglyceride level was 97.0 ± 3.5 mg/dL. Table 1 showed
the clinical characteristics stratified by MetS among the
elderly male population.
The prevalence and components of MetS in Asian geriatrics
According to the 2005 NCEP-ATPIII definition of MetS,
the prevalence of MetS was 36.4%. Excluding DM, the
prevalence was 27.8%, which was lower than the previ-
ously reported data for Caucasians [28]. Because MetS
was composed of multiple components and mostly defined
from younger aged adult populations, we were interested
in which component played the most dominant roles in
this geriatric community. The most common diagnostic
factor for MetS was hypertension, followed by a large
waist circumference, low HDL-C, high fasting glucose,
and high triglycerides (Table 1).
The associations between MetS, inflammation and
physical activity
Among novel inflammatory biomarkers, hsCRP was mea-
sured in this Asian geriatric cohort to indicate the individual
inflammation status. The median plasma hsCRP level was
1.3 ± 0.3 mg/L in the total population, and was significantly
higher in the MetS sub-group than non-MetS sub-group
(1.6 ± 0.7 vs. 1.0 ± 0.3 mg/L, p < 0.01) (Figure 1A). Further-
more, the risk of elevated hsCRP increased with escalating
MetS components (p for trend < 0.001). The risk of a diag-
nosis of MetS was significantly higher for those with the
highest when compared with those who having the lowest
quartile of hsCRP levels (ORs: 2.767, 95% CI: 1.315-5.821,p < 0.01). All these evidence support the pathophysiologic
correlation between geriatric MetS and inflammation.
The amount of physical activity recorded from our
individual questionnaire was compared and analyzed
between different metabolic components as well as the
inflammatory biomarkers. The non-MetS group had
higher amount of median weekly physical activity
(non-MetS vs. MetS group: 183.1 ± 19.0 vs. 173.5 ± 10.6
MET-hr/week, p = 0.029) (Figure 1B). The physical activity
amount was also higher among those with lower hsCRP
levels (higher vs. lower hsCRP: 167.8 ± 38.5 vs. 186.1 ± 14.1
MET-hr/week, p = 0.013) (Figure 1C). This implied that
Figure 1 The associations between MetS, inflammation and
physical activity. A. The level of hsCRP stratified by MetS, hsCRP in
MetS: 1.6 (1, 3.2) mg/L, hsCRP in non-MetS: 1.0 (0.5, 2.6) mg/L. B. The
amount of weekly physical activity stratified by MetS. C. The amount of
weekly physical activity stratified by the level of hsCRP >3.0 mg/L.
hsCRP = high-sensitivity C-reactive protein, MetS = metabolic syndrome.
Figure 2 Interaction between individual MetS components and
inflammation. Odds ratio (95% CI) for high hsCRP plasma levels
with MetS, according to absence (−) or presence (+) of single MetS
components. HDL-C = high-density lipoprotein, hsCRP = high-sensitivity
C-reactive protein, MetS =metabolic syndrome, TG= triglycerides,
CI = confidence interval.
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flammation status indicated by the hsCRP level.
Individual MetS components and inflammation
To understand the role of plasma hsCRP level in MetS, the
participants with MetS were post hoc subdivided into
two groups according to their individual MetS components
(Figure 2). We used the ORs for the highest hsCRP level
from the entire study population with MetS as the standard
baseline to analyze the variation between the ORs from
those with and without individual MetS risk components.
The variation in ORs from MetS participants with-or-
without a low HDL-C level was the greatest of the five
traditional risk components of MetS. These data indicated
that HDL-C level might have the greatest interaction with
the plasma hsCRP level. In addition, multivariate analysiswith adjustment for physical activity showed that a low
HDL-C level was the strongest predictor for higher hsCRP
in MetS among all risk components (ORs: 6.318, 95% CI:
1.563-25.536, p < 0.05) (Table 2).
Individual MetS components and physical activity
Since the physical activity was associated with the
prevalence rate of MetS, we also analyzed its association
with individual MetS components (Figure 3). We found
that either those with lower waist circumference (higher
vs. lower: 165.9 ± 24.8 vs. 185.5 ± 17.2 MET-hr/week,
p = 0.048) or higher levels of HDL-C (higher vs. lower:
186.1 ± 18.7 vs. 170.6 ± 11.3 MET-hr/week, p = 0.003)
had a higher median weekly physical activity. But this
phenomenon was not significant regarding hypertension,
glucose control or triglyceride level.
Multiple risk factors analysis
Multivariate analysis showed that BMI (ORs: 1.527, 95% CI:
1.319-1.768, p < 0.01), insulin (OR: 1.128, 95% CI: 1.045-
1.218, p < 0.01) and physical activity (ORs: 0.997, 95%
IC: 0.994-0.999, p < 0.05), rather than the level of hsCRP
(ORs: 1.022, 95% CI: 0.965-1.082, p > 0.05) were independ-
ent predictors of MetS (Table 3).
Discussion
Among this elderly community survey, we found an
interesting interplay between inflammation and physical
activity for the development of MetS. In this geriatric
cohort, only the physical activity amount plays the most
important role in the pathophysiology of elderly MetS.
Though the inflammation may interact with individual
risk component in MetS, it remains as a phenomenon
associated with the average weekly activity per se.
Table 2 Individual MetS component and physical activity
associated with high hsCRP plasma levels in MetS
ORs 95% CI P
HDL-C 6.318 1.563-25.536 0.010
Waist 3.031 0.898-10.235 0.074
TG 1.512 0.518-4.412 0.449
Fasting glucose 1.251 0.424-3.692 0.685
Hypertension 1.139 0.215-6.039 0.878
Physical activity 1.000 0.995-1.005 0.967
Abbreviations: hsCRP = high-sensitivity C-reactive protein; MetS =metabolic
syndrome; ORs = odds ratios; CI = confidence intervals; HDL-C = high-density
lipoprotein; TG = triglyceride.
Table 3 Multivariate analysis of physical and biomarker
risk factors for MetS among elderly male population
Factor ORs 95% CI P
BMI 1.527 1.319-1.768 0.001
Insulin 1.128 1.045-1.218 0.002
Physical activity 0.997 0.994-0.999 0.036
LDL-C 0.976 0.946-1.007 0.132
Cholesterol 1.018 0.990-1.046 0.210
Smoking, current 1.639 0.695-3.865 0.259
hsCRP 1.022 0.965-1.082 0.455
Age 1.008 0.954-1.064 0.777
Abbreviations: MetS =metabolic syndrome; ORs = odds ratios; CI = confidence
intervals; LDL-C = low-density lipoprotein; hsCRP = high-sensitivity
C-reactive protein.
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In this special cohort, we surveyed a remote community
with a low level of economic development and low socio-
economic status in southern Taiwan. Most of the residents
were farmers whose non-MetS population engaged in
substantially more average weekly physical activities than
the MetS population. At the same time, they also had
lower hsCRP levels, which were generally considered
as an indicator of lower inflammatory status.
Previous report showed that physical activity is an
effective way to increased human HDL-C [29,30], which
was also associated with a higher-level of physical activity
as well as hsCRP [11,31]. Indeed, Dai et al. [29] observed
another Taiwanese population cohort and found that a high
level of physical activity was associated with increased
HDL-C levels. Geffken et al. [22] also reported that a
high level physical activity might decrease plasma hsCRP
level. These data support the notion that physical activity is
related to inflammation status, and in our cohort, more
physically active participants had lower-grade inflammation
biomarkers, i.e., hsCRP levels. Instead of hsCRP, the only
remained multivariable predictor for MetS was physical
activity amount. We thus hypothesized that inflammationFigure 3 The median of weekly physical activity stratified by the
level of each MetS components. HDL-C = high-density lipoprotein,
HTN = Hypertension, MetS =metabolic syndrome, TG = triglycerides. **:
p < 0.01; *: p < 0.05; NS = not significant. (Blue column: positive for
individual risk factor; Red column: negative for individual risk factor).process might be an intermittent phenomenon due to
their limited physical activity.
Lower HDL-C level may interact with hsCRP level in MetS
Our analytic model analyzed the interaction between
individual risk components with inflammation among
patients with MetS by dividing them into two groups,
based on whether or not they had the existing individual
MetS component. Interestingly, we found that the variation
between risks of higher hsCRP was greatest within the
HDL-C level, which indicated that HDL-C level might have
the greatest interaction with the plasma hsCRP level in the
traditional MetS risk factors. Previous report showed that
physical activity is an effective way to increased human
HDL-C [29,30], which was also associated with hsCRP
[11,31]. But after adjustment for physical activity, the
interaction was still remained. ATP-binding membrane
cassette transporter A1 (ABCA1) is a possible link between
inflammation and reverse cholesterol transport [32]. The
function of ABCA1 in modulating the immune response
and inflammation works through its direct and indirect
antiinflammatory mechanisms including lipid transport,
HDL-C formation and apoptosis. These facts support
the hypothesis that HDL-C may interact with plasma
hsCRP through this ABCA1 pathophysiologic pathway,
instead of mechanism from physical activity modulation.
Compared with a previous report on a Caucasian cohort
[33], this is unique and deserves an additional genetic or a
larger cohort survey.
Central obesity is associated with hsCRP level in MetS
In our study cohort, once we excluded those with a waist
circumference ≥ 90 cm, there was no difference in the
plasma hsCRP levels between the MetS and non-MetS
groups. This analysis implied that waist circumference,
or so-called “central obesity”, greatly contributes to the
inflammation in MetS. In this geriatric cohort, the vari-
ation in ORs from the MetS and non-MetS groups with
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which indicated that central obesity, rather than fasting
glucose and triglyceride levels, might also interact with
inflammation. The InCHIANTI study [33] showed that
waist circumference was the major reason for elevated
plasma hsCRP levels. The measurement of waist circum-
ference is commonly recommended as a useful tool for
clinically assessing visceral fat accumulation [34,35]. In
our study, the median value of the hsCRP level was sig-
nificantly higher in the MetS group than in the non-
MetS group. However, once we excluded those without
large waist circumferences, there was no significant
difference in the plasma hsCRP level. This subtraction
data suggested that central obesity has an important
interaction with inflammation, which is indicated by a
higher hsCRP level.
Plasma hsCRP levels vary between Caucasians and Asians
Previous studies [36,37] have suggested hsCRP level may
differ by ethnicity. Ye et al. [38] reported one median value
of hsCRP level from a Chinese population 50–70 years old
and living in Beijing and Shanghai to be 0.68 mg/L, which
was lower than the reported [39] Caucasian level. The
Study of Women’s Health Across the Nation [37] reported
that the median values of hsCRP of Japanese and Chinese
women were both also lower than the Caucasian subjects
(0.5 mg/L vs. 0.7 mg/L and 1.4 mg/L). Regarding the gender
comparison, the report from the Intermountain Heart
Collaborative Study Group showed a significant higher
mean hsCRP level was observed in American woman
(woman vs. man: 1.47 mg/dL vs. 1.30 mg/dL, p < 0.001)
[40]. In general, the level of hsCRP was higher in Caucasian
population and also higher among the women in gender.
Our current study surveyed only gentleman within this
remote geriatric community. Compared with prior younger
cohort studies, our study showed a relatively higher median
level of hsCRP (1.3 mg/L). The higher level of hsCRP could
only partially explained by the nature aging process,
because aging per se has been associated with increased
inflammatory status also other degenerative disorders
[41]. However, further studies comparing both genders
in the same region were mandatory.
MetS component distribution may vary between
different cohorts
The pathophysiological relationship between MetS and its
individual components is not well understood. Traditional
concepts recognize “central obesity” and “insulin resistance”
as the 2 major pathogenic factors [5]. In the InCHIANTI
study [33], the most common diagnostic factor was hyper-
tension (28.1%), followed by large waist circumference
(22.8%), high triglycerides (17.2%), high fasting glucose
(16.3%), and low HDL-C (15.6%). In our study, the most 2
common diagnostic factors were also hypertension (25.9%)and a large waist circumference (21.5%). Interestingly,
our third most common MetS diagnostic factor was low
HDL-C (20.6%) rather than high triglycerides, which was
the least common factor. These data also raise the consider-
ation that various weighting ratios for individual metabolic
risk components may be appropriate for different ethnic
backgrounds. For example, compared with the InCHIANTI
study, a lower level of HDL-C in our study seemed more
important than a higher triglyceride level geriatric MetS in
the Taiwanese population.
Limitations
In addition to limited number in our local community
study, this unique field study remained limited because
of several important confounding and study design fac-
tors. First, our study cohort enrolled only men. Whether
there are significant gender differences in the patho-
physiology of MetS [42] deserves additional investiga-
tion. Second, our study participants were all over 65, so
the survival effect cannot be excluded. Third, we studied
only a rural population. Aekplakorn et al. [43] have shown
that MetS affected both urban and rural populations with
different patterns of MetS combinations. Fourth, our
participants were volunteers but not randomly sampled,
which might be biased because of the decreased partici-
pation rate of disabled persons. Fifth, we did not screen
for their whole dietary habits. Dietary habit may be a
main link the difference in prevalence of MetS between
Western and Eastern countries. Interestingly, we previ-
ously reported another behavior as tea drinking to be
a negative predictor for MetS [8]. Culture-associated
differences in dietary and daily activity actually play
important roles pathophysiologically. Finally, plasma
hsCRP was examined only once in our study. It was
unknown whether the hsCRP level fluctuated in that
elderly population.
Conclusion
From this remote male cohort data, we demonstrated
that Asian geriatric MetS had different metabolic profiles
than the Caucasian populations. In addition, we concluded
that different from central obesity in Caucasian cohort, the
reduced physical activity was the major pathophysiological
MetS factor in our Asian geriatric participants.
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